CyanoacrylateType IV hypersensitivity reaction and hypersensitivity reaction: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1980卷 / 1期

关键词：

D O I：

10.1007/s40278-023-48328-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：136 / 136

相关论文

共 50 条

[21] InfliximabInfusion reaction and delayed hypersensitivity reaction: 3 case reports
Reactions Weekly, 2019, 1753 (1) : 196 - 196
[22] CarboplatinCarboplatin hypersensitivity reaction: 16 case reports
Reactions Weekly, 2017, 1658 (1) : 112 - 112
[23] RituximabImmediate hypersensitivity reaction: 24 case reports
Reactions Weekly, 2020, 1809 (1) : 213 - 213
[24] AntineoplasticsImmediate hypersensitivity reaction: 22 case reports
Reactions Weekly, 2023, 1944 (1) : 82 - 82
[25] IbuprofenDrug hypersensitivity reaction: 4 case reports
Reactions Weekly, 2020, 1826 (1) : 156 - 156
[26] TozinameranImmediate hypersensitivity reaction: 3 case reports
Reactions Weekly, 2022, 1892 (1) : 232 - 232
[27] TocilizumabImmediate hypersensitivity reaction: 5 case reports
Reactions Weekly, 2015, 1535 (1) : 203 - 203
[28] LenalidomideDelayed hypersensitivity reaction: 5 case reports
Reactions Weekly, 2014, 1532 (1) : 137 - 137
[29] DupilumabImmediate hypersensitivity reaction: 5 case reports
Reactions Weekly, 2023, 1983 (1) : 185 - 185
[30] TopotecanType IV hypersensitivity reaction: case report
Reactions Weekly, 2016, 1606 (1) : 161 - 161

← 1 2 3 4 5 →